Medical communities of the simulation learning platform are only available to registered users. Log in to the Platform with your login and password. After logging in, select communities either in the top drop-down menu or in the shortcut menu. The simulation training platform currently has more than 100 medical communities. Communities are designed to allow doctors to freely:
seek advice from colleagues;
discuss complex clinical cases;
help each other;
reduce medical errors;
The medical communities of the Platform are divided according to the principles of specializations and languages of communication. Currently, the simulation training platform has created communities in more than 35 medical specialities.
The groups are based on user-friendly languages: English, Ukrainian and Russian. You can use page navigation to find the community you need. You can sort the display by tile or list. You can also search using the search box.
Once a user registers on the Platform, they are automatically invited to join the Platform’s medical communities. Platform administrators and moderators also send you invitations to an E-mail address according to your specialities.
Join the medical communities of the “ClincaceQuest” simulation training platform right now!
Register on our website right now to have access to more learning materials!
AMEE 2023 took place from 26-30 August 2023 at the Scottish Event Campus (SEC), Glasgow,…
We are thrilled to announce that our Simulation Training Platform “ClinCaseQuest” has been featured on…
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies (Anthracycline Chemotherapy) – Online Calculator
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies (Anthracycline Chemotherapy)…
The National Institutes of Health Stroke Scale (NIHSS) is a scale designed to assess the…
We are at SESAM 2023 with oral presentation “Stage Debriefing in Simulation Training in Medical…
Charlson Comorbidity Index predicts 10-year survival in patients with multiple comorbidities.